Dementia Risk of Direct Oral Anticoagulants Versus Warfarin for Atrial Fibrillation

Khi Yung Fong; Yiong Huak Chan; Yue Wang; Colin Yeo; Barbara Helen Rosario; Professor Gregory Lip; Vern Hsen Tan

doi:10.1016/j.jacasi.2023.07.012

Abstract

1 min read

The use of DOAC in AF significantly reduces dementia risk compared with warfarin, particularly in Asian patients. The possible reversal of this effect with increasing age merits further randomized trials with long-term follow-up. (Dementia Risk of Direct Oral Anticoagulants Versus Warfarin for Atrial Fibrillation: A Systematic Review and Meta-Analysis; CRD42022365634).

Discussion(0)

No comments yet. Be the first to comment.

Related publications

Article2021

Comparing Warfarin and 4 Direct Oral Anticoagulants for the Risk of Dementia in Patients With Atrial Fibrillation

So-Ryoung Lee, Eue-Keun Choi, Sang Hyun Park, Jin‐Hyung Jung, Kyungdo Han, Seil Oh, Professor Gregory Lip

Article2019

Nonvitamin K Antagonist Oral Anticoagulants Versus Warfarin in Atrial Fibrillation Patients and Risk of Dementia: A Nationwide Propensity‐Weighted Cohort Study

Mette Søgaard, Flemming Skjøth, Martin Jensen, Jette Nordstrøm Kjældgaard, Professor Gregory Lip, Torben Bjerregaard Larsen, Peter Brønnum Nielsen

Article2020

Comparison between non-vitamin K antagonist oral anticoagulants versus warfarin for the risk of dementia in Asian patients with non-valvular atrial fibrillation

S.R Lee, E K Choi, Sunyoung Park, Kyungdo Han, Seil Oh, Professor Gregory Lip

Article2019

P4789Comparisons of direct oral anticoagulants and warfarin in patients with atrial fibrillation and liver cirrhosis

Tze‐Fan Chao, Professor Gregory Lip, S A Chen

Article2023

Risk of incident atrial fibrillation and subsequent use of oral anticoagulants in patients with dementia

Tze‐Fan Chao, Ling Kuo, Professor Gregory Lip, S A Chen